These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 16542646)
1. Acute PKCdelta inhibition limits ischaemia-reperfusion injury in the aged rat heart: role of GSK-3beta. Kostyak JC; Hunter JC; Korzick DH Cardiovasc Res; 2006 May; 70(2):325-34. PubMed ID: 16542646 [TBL] [Abstract][Full Text] [Related]
2. Local delivery of PKCepsilon-activating peptide mimics ischemic preconditioning in aged hearts through GSK-3beta but not F1-ATPase inactivation. Korzick DH; Kostyak JC; Hunter JC; Saupe KW Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2056-63. PubMed ID: 17675573 [TBL] [Abstract][Full Text] [Related]
3. Ischaemic post-conditioning protects both adult and aged Sprague-Dawley rat heart from ischaemia-reperfusion injury through the phosphatidylinositol 3-kinase-AKT and glycogen synthase kinase-3beta pathways. Yin Z; Gao H; Wang H; Li L; Di C; Luan R; Tao L Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):756-63. PubMed ID: 19207715 [TBL] [Abstract][Full Text] [Related]
4. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling. Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553 [TBL] [Abstract][Full Text] [Related]
5. Cordycepin, 3'-deoxyadenosine, prevents rat hearts from ischemia/reperfusion injury via activation of Akt/GSK-3β/p70S6K signaling pathway and HO-1 expression. Park ES; Kang DH; Yang MK; Kang JC; Jang YC; Park JS; Kim SK; Shin HS Cardiovasc Toxicol; 2014 Mar; 14(1):1-9. PubMed ID: 24178833 [TBL] [Abstract][Full Text] [Related]
6. Aprotinin abolishes sevoflurane postconditioning by inhibiting nitric oxide production and phosphorylation of protein kinase C-delta and glycogen synthase kinase 3beta. Inamura Y; Miyamae M; Sugioka S; Kaneda K; Okusa C; Onishi A; Domae N; Kotani J; Figueredo VM Anesthesiology; 2009 Nov; 111(5):1036-43. PubMed ID: 19809279 [TBL] [Abstract][Full Text] [Related]
7. GSK-3β at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways. Vigneron F; Dos Santos P; Lemoine S; Bonnet M; Tariosse L; Couffinhal T; Duplaà C; Jaspard-Vinassa B Cardiovasc Res; 2011 Apr; 90(1):49-56. PubMed ID: 21233250 [TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism. Ha T; Hua F; Liu X; Ma J; McMullen JR; Shioi T; Izumo S; Kelley J; Gao X; Browder W; Williams DL; Kao RL; Li C Cardiovasc Res; 2008 Jun; 78(3):546-53. PubMed ID: 18267957 [TBL] [Abstract][Full Text] [Related]
9. Effect of pressure overload on cardioprotection of mitochondrial KATP channels and GSK-3beta: interaction with the MPT pore. Mozaffari MS; Schaffer SW Am J Hypertens; 2008 May; 21(5):570-5. PubMed ID: 18437149 [TBL] [Abstract][Full Text] [Related]
11. Adrenomedullin protects against myocardial apoptosis after ischemia/reperfusion through activation of Akt-GSK signaling. Yin H; Chao L; Chao J Hypertension; 2004 Jan; 43(1):109-16. PubMed ID: 14662648 [TBL] [Abstract][Full Text] [Related]
12. Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK. Jeong CW; Yoo KY; Lee SH; Jeong HJ; Lee CS; Kim SJ J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):387-94. PubMed ID: 22396328 [TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus abrogates the cardioprotection of sufentanil against ischaemia/reperfusion injury by altering glycogen synthase kinase-3β. Chen QL; Gu EW; Zhang L; Cao YY; Zhu Y; Fang WP Acta Anaesthesiol Scand; 2013 Feb; 57(2):236-42. PubMed ID: 22881281 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of glycogen synthase kinase-3beta improves tolerance to ischemia in hypertrophied hearts. Barillas R; Friehs I; Cao-Danh H; Martinez JF; del Nido PJ Ann Thorac Surg; 2007 Jul; 84(1):126-33. PubMed ID: 17588398 [TBL] [Abstract][Full Text] [Related]
15. Cardioprotection by GSK-3 inhibition: role of enhanced glycogen synthesis and attenuation of calcium overload. Omar MA; Wang L; Clanachan AS Cardiovasc Res; 2010 Jun; 86(3):478-86. PubMed ID: 20053658 [TBL] [Abstract][Full Text] [Related]
16. Remifentanil Preconditioning Reduces Postischemic Myocardial Infarction and Improves Left Ventricular Performance via Activation of the Janus Activated Kinase-2/Signal Transducers and Activators of Transcription-3 Signal Pathway and Subsequent Inhibition of Glycogen Synthase Kinase-3β in Rats. Qiao S; Mao X; Wang Y; Lei S; Liu Y; Wang T; Wong GT; Cheung CW; Xia Z; Irwin MG Crit Care Med; 2016 Mar; 44(3):e131-45. PubMed ID: 26468894 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin II-preconditioning is associated with increased PKCε/PKCδ ratio and prosurvival kinases in mitochondria. Nuñez RE; Javadov S; Escobales N Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1201-1212. PubMed ID: 28707739 [TBL] [Abstract][Full Text] [Related]
18. Ventricular hypertrophy abrogates intralipid-induced cardioprotection by alteration of reperfusion injury salvage kinase/glycogen synthase kinase 3β signal. Ma LL; Ge HW; Kong FJ; Qian LB; Hu BC; Li Q; Xu L; Liu JQ; Xu YX; Sun RH Shock; 2014 May; 41(5):435-42. PubMed ID: 24430545 [TBL] [Abstract][Full Text] [Related]
19. Morphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3β pathway independent of PI3K/Akt. He SF; Jin SY; Wu H; Wang B; Wu YX; Zhang SJ; Irwin MG; Wong TM; Zhang Y Toxicol Appl Pharmacol; 2015 Nov; 288(3):349-58. PubMed ID: 26296503 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of sphingosine-1-phosphate induced cardioprotection against I/R injury in diabetic rat heart: Possible involvement of glycogen synthase kinase 3β and mitochondrial permeability transition pore. Rana A; Sharma S Clin Exp Pharmacol Physiol; 2016 Feb; 43(2):166-73. PubMed ID: 26582369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]